D-2.6.1. Ends Day 90, As Needed
The fiscal analysis is reviewed internally and prepared for submission to external parties.
- Actuarial Analysis reviews to determine if the expected cost of the drug requires an adjustment to managed care rates.
- Actuarial analysis makes a recommendation regarding risk status.
- Based on a drug’s estimated fiscal impact, Provider Finance Department (PFD) determines what type of notice to or approval from the LBB is required. If approval is needed, VDP and the Financial Services Division coordinate to obtain the necessary approval.